Clonal spread of Klebsiella pneumoniae producing CMY-2 AmpC-type beta-lactamase in surgical intensive care units

J Microbiol Immunol Infect. 2009 Dec;42(6):479-87.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cefoxitin / therapeutic use
  • Ceftazidime / therapeutic use
  • Cephalosporin Resistance
  • Critical Care / statistics & numerical data
  • Cross Infection / epidemiology
  • Cross Infection / microbiology*
  • Electrophoresis, Gel, Pulsed-Field
  • Female
  • Humans
  • Isoelectric Focusing
  • Klebsiella Infections / drug therapy
  • Klebsiella Infections / epidemiology
  • Klebsiella Infections / microbiology*
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / enzymology*
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Phenotype
  • Retrospective Studies
  • Taiwan / epidemiology
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Cefoxitin
  • Ceftazidime
  • beta-lactamase CMY-2
  • beta-Lactamases